Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study

Anders Mälarstig, Alfonso Buil, Juan Carolos Souto, Robert Clarke, Francisco Blanco-Vaca, Jordi Fontcuberta, John Peden, Malin Andersen, Angela Silveira, Simona Barlera, Udo Seedorf, Hugh Watkins, Laura Almasy, Anders Hamsten, José Manuel Soria

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Total plasma homocysteine concentration (tHcy) is a biomarker for atherothrombotic disease, but causality remains uncertain. Polymorphisms in the genes involved in methionine metabolism explain only a small fraction of the heritability of tHcy levels. In a genome-wide association study, we examined the genetic determinants of tHcy using a 2-stage design. First, 283 437 single nucleotide polymorphisms (SNPs) were tested for association with tHcy in 387 persons recruited from 21 large Spanish families. Of those, 17 SNPs showed equal or stronger association with tHcy level compared with the MTHFR 677C>T SNP (β = 0.10, P = .0001). Second, a replication analysis of these 17 SNPs was performed in patients with premature myocardial infarction (n = 1238). Novel associations were found for SNPs near the ZNF366 gene (lead SNP rs7445013; discovery stage: adjusted β = -0.12, P = 5.30 × 10-6, replication stage: adjusted β = -0.13, P = .004) and the PTPRD gene (lead SNP rs973117; discovery stage: adjusted β = 0.11, P = 5.5 × 10 -6, replication stage: adjusted β = 0.10, P = .005). These associations were independent of known confounders, including creatinine clearance and plasma fibrinogen concentration. Our findings implicate novel pathways in homocysteine metabolism, and highlight the need for investigation of the associated genes in the etiology of vascular diseases.

Original languageEnglish
Pages (from-to)1417-1422
Number of pages6
JournalBlood
Volume114
Issue number7
DOIs
Publication statusPublished - 2009

Fingerprint

Genome-Wide Association Study
Homocysteine
Polymorphism
Single Nucleotide Polymorphism
Genes
Association reactions
Nucleotides
Plasmas
Metabolism
Vascular Diseases
Causality
Methionine
Biomarkers
Fibrinogen
Creatinine
Myocardial Infarction

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Mälarstig, A., Buil, A., Souto, J. C., Clarke, R., Blanco-Vaca, F., Fontcuberta, J., ... Soria, J. M. (2009). Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. Blood, 114(7), 1417-1422. https://doi.org/10.1182/blood-2009-04-215269

Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. / Mälarstig, Anders; Buil, Alfonso; Souto, Juan Carolos; Clarke, Robert; Blanco-Vaca, Francisco; Fontcuberta, Jordi; Peden, John; Andersen, Malin; Silveira, Angela; Barlera, Simona; Seedorf, Udo; Watkins, Hugh; Almasy, Laura; Hamsten, Anders; Soria, José Manuel.

In: Blood, Vol. 114, No. 7, 2009, p. 1417-1422.

Research output: Contribution to journalArticle

Mälarstig, A, Buil, A, Souto, JC, Clarke, R, Blanco-Vaca, F, Fontcuberta, J, Peden, J, Andersen, M, Silveira, A, Barlera, S, Seedorf, U, Watkins, H, Almasy, L, Hamsten, A & Soria, JM 2009, 'Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study', Blood, vol. 114, no. 7, pp. 1417-1422. https://doi.org/10.1182/blood-2009-04-215269
Mälarstig, Anders ; Buil, Alfonso ; Souto, Juan Carolos ; Clarke, Robert ; Blanco-Vaca, Francisco ; Fontcuberta, Jordi ; Peden, John ; Andersen, Malin ; Silveira, Angela ; Barlera, Simona ; Seedorf, Udo ; Watkins, Hugh ; Almasy, Laura ; Hamsten, Anders ; Soria, José Manuel. / Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. In: Blood. 2009 ; Vol. 114, No. 7. pp. 1417-1422.
@article{a27993f9859c4285ace4cde6dfb527ae,
title = "Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study",
abstract = "Total plasma homocysteine concentration (tHcy) is a biomarker for atherothrombotic disease, but causality remains uncertain. Polymorphisms in the genes involved in methionine metabolism explain only a small fraction of the heritability of tHcy levels. In a genome-wide association study, we examined the genetic determinants of tHcy using a 2-stage design. First, 283 437 single nucleotide polymorphisms (SNPs) were tested for association with tHcy in 387 persons recruited from 21 large Spanish families. Of those, 17 SNPs showed equal or stronger association with tHcy level compared with the MTHFR 677C>T SNP (β = 0.10, P = .0001). Second, a replication analysis of these 17 SNPs was performed in patients with premature myocardial infarction (n = 1238). Novel associations were found for SNPs near the ZNF366 gene (lead SNP rs7445013; discovery stage: adjusted β = -0.12, P = 5.30 × 10-6, replication stage: adjusted β = -0.13, P = .004) and the PTPRD gene (lead SNP rs973117; discovery stage: adjusted β = 0.11, P = 5.5 × 10 -6, replication stage: adjusted β = 0.10, P = .005). These associations were independent of known confounders, including creatinine clearance and plasma fibrinogen concentration. Our findings implicate novel pathways in homocysteine metabolism, and highlight the need for investigation of the associated genes in the etiology of vascular diseases.",
author = "Anders M{\"a}larstig and Alfonso Buil and Souto, {Juan Carolos} and Robert Clarke and Francisco Blanco-Vaca and Jordi Fontcuberta and John Peden and Malin Andersen and Angela Silveira and Simona Barlera and Udo Seedorf and Hugh Watkins and Laura Almasy and Anders Hamsten and Soria, {Jos{\'e} Manuel}",
year = "2009",
doi = "10.1182/blood-2009-04-215269",
language = "English",
volume = "114",
pages = "1417--1422",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "7",

}

TY - JOUR

T1 - Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study

AU - Mälarstig, Anders

AU - Buil, Alfonso

AU - Souto, Juan Carolos

AU - Clarke, Robert

AU - Blanco-Vaca, Francisco

AU - Fontcuberta, Jordi

AU - Peden, John

AU - Andersen, Malin

AU - Silveira, Angela

AU - Barlera, Simona

AU - Seedorf, Udo

AU - Watkins, Hugh

AU - Almasy, Laura

AU - Hamsten, Anders

AU - Soria, José Manuel

PY - 2009

Y1 - 2009

N2 - Total plasma homocysteine concentration (tHcy) is a biomarker for atherothrombotic disease, but causality remains uncertain. Polymorphisms in the genes involved in methionine metabolism explain only a small fraction of the heritability of tHcy levels. In a genome-wide association study, we examined the genetic determinants of tHcy using a 2-stage design. First, 283 437 single nucleotide polymorphisms (SNPs) were tested for association with tHcy in 387 persons recruited from 21 large Spanish families. Of those, 17 SNPs showed equal or stronger association with tHcy level compared with the MTHFR 677C>T SNP (β = 0.10, P = .0001). Second, a replication analysis of these 17 SNPs was performed in patients with premature myocardial infarction (n = 1238). Novel associations were found for SNPs near the ZNF366 gene (lead SNP rs7445013; discovery stage: adjusted β = -0.12, P = 5.30 × 10-6, replication stage: adjusted β = -0.13, P = .004) and the PTPRD gene (lead SNP rs973117; discovery stage: adjusted β = 0.11, P = 5.5 × 10 -6, replication stage: adjusted β = 0.10, P = .005). These associations were independent of known confounders, including creatinine clearance and plasma fibrinogen concentration. Our findings implicate novel pathways in homocysteine metabolism, and highlight the need for investigation of the associated genes in the etiology of vascular diseases.

AB - Total plasma homocysteine concentration (tHcy) is a biomarker for atherothrombotic disease, but causality remains uncertain. Polymorphisms in the genes involved in methionine metabolism explain only a small fraction of the heritability of tHcy levels. In a genome-wide association study, we examined the genetic determinants of tHcy using a 2-stage design. First, 283 437 single nucleotide polymorphisms (SNPs) were tested for association with tHcy in 387 persons recruited from 21 large Spanish families. Of those, 17 SNPs showed equal or stronger association with tHcy level compared with the MTHFR 677C>T SNP (β = 0.10, P = .0001). Second, a replication analysis of these 17 SNPs was performed in patients with premature myocardial infarction (n = 1238). Novel associations were found for SNPs near the ZNF366 gene (lead SNP rs7445013; discovery stage: adjusted β = -0.12, P = 5.30 × 10-6, replication stage: adjusted β = -0.13, P = .004) and the PTPRD gene (lead SNP rs973117; discovery stage: adjusted β = 0.11, P = 5.5 × 10 -6, replication stage: adjusted β = 0.10, P = .005). These associations were independent of known confounders, including creatinine clearance and plasma fibrinogen concentration. Our findings implicate novel pathways in homocysteine metabolism, and highlight the need for investigation of the associated genes in the etiology of vascular diseases.

UR - http://www.scopus.com/inward/record.url?scp=70349330246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349330246&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-04-215269

DO - 10.1182/blood-2009-04-215269

M3 - Article

VL - 114

SP - 1417

EP - 1422

JO - Blood

JF - Blood

SN - 0006-4971

IS - 7

ER -